Related Experiment Video

Updated: Jul 8, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer

R E Roses1, M Xu, G K Koski

  • 1Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA. brian.czerniecki@uphs.upenn.edu

Oncogene
|January 8, 2008
PubMed

Insights

Toll-like receptor (TLR) agonists show promise for cancer immunotherapy by boosting immune responses. Combining TLR-targeted therapies with radiation may enhance antitumor immunity, offering a promising multimodality approach.

Area of Science:

  • Immunology
  • Oncology
  • Radiotherapy

Background:

  • Pathogen-associated molecular patterns (PAMPs) activate Toll-like receptors (TLRs), initiating immune responses.
  • TLR activation is a promising strategy for developing novel cancer immunotherapies.
  • Radiation therapy's role in cancer treatment is evolving beyond its traditional immunosuppressive view.

Purpose of the Study:

  • To review evidence for radiation enhancing anti-tumor immunity.
  • To explore the synergistic effects of radiation and TLR-targeted immunotherapies.
  • To highlight the potential of combining radiation with novel immune interventions.

Main Methods:

  • Review of existing scientific literature and preclinical/clinical data.
  • Analysis of mechanisms by which radiation influences the tumor microenvironment and immune response.
  • Examination of TLR-dependent pathways activated by radiation.

Main Results:

  • Radiation therapy can enhance tumor-associated antigen expression and reduce regulatory T cell activity.
  • Radiation may activate innate immunity via TLR-dependent mechanisms, augmenting adaptive anti-cancer responses.
  • Early data suggest synergistic effects between radiation and TLR-targeted immunotherapies.

Conclusions:

  • Radiation therapy can be a valuable adjunct to cancer immunotherapy.
  • Combining radiation with TLR-targeted strategies holds significant potential for improving antitumor immunity.
  • Multimodality approaches integrating radiation and immunotherapy represent a promising future direction for cancer treatment.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...